Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal oxytocin for acute migraine headache
ACTRN12607000384459Phase 2Not yet recruiting
- Sponsor
- Trigemina, Inc.
- Start
- Sep 2007
- Modality
- Recombinant Proteins and Enzymes, Peptides
01
Overview
Phase 2 trial of oxytocin in migraine (2 arms), sponsored by Trigemina, Inc. Planned start Sep 2007; status: not yet recruiting.
02
Drugs
oxytocin
03
Conditions
migraine
Beyond the preview
Go deeper on ACTRN12607000384459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000384459.